-
Federal Support for Cancer Research Takes the Stage at AACR Annual Meeting
Scientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Forward Look
Controlling Cancer Without SurgeryImmunotherapy can induce a complete response in some people with mismatch repair-deficient cancers.
by Thomas Celona
-
Alleviating Skin Side Effects in Colorectal Cancer
A clinical trial finds a topical gel can decrease acneiform rash and improve quality of life in people being treated for colorectal cancer.
by Thomas Celona
-
At-home Prostate Cancer Test May Help Some Men Avoid Biopsy
The test, which analyzes urine for 18 cancer-specific genes, ruled out the need for biopsy in men with elevated PSA without a digital rectal exam.
by Sandra Gordon
-
Melanoma Risk in Childhood Cancer Survivors
People treated for childhood cancer found to have twice the risk of developing melanoma as an adult.
by Cameron Walker
-
Online Second Opinions
More than half of patients who participated in a program offering online second opinions were recommended a change to their treatment plan.
by Eric Fitzsimmons
-
Musical Toxicity an Effect of Cancer Treatment
Study finding cancer treatment affects ability to play or sing music highlights need for physical therapy, experts say.
by Kyle Bagenstose
-
Treatment Lags Behind Guidelines for Many Men With Prostate Cancer
Guidelines for treating advanced prostate cancer changed in 2017, but a recent study indicated many patients were not being treated accordingly.
by Laura Gesualdi Gilmore
-
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles